Review of Male and Female Care Needs in Schizophrenia: A New Specialized Clinical Unit for Women
Abstract
:1. Introduction
2. Results
2.1. Mental Health Problems of Women with Schizophrenia
2.2. Medical Issues
2.3. Parental and Social Issues
3. Currently Offered Women-Centered Programs and Discussion of Findings
3.1. Therapeutic Drug Monitoring/Adherence Program
3.2. Individual/Group Patient and Family Sessions
3.3. Collaborative Programs (Primary Care)
3.4. Collaborative Programs (Other Medical Specialties)
3.5. Suicide Risk—Prevention and Intervention
3.6. Perinatal Mental Health
3.7. Social Services
3.8. Home-Based Services
3.9. Peer and Family Support
3.10. Occupational Therapies
3.11. Physical Activity and Leisure Programs
3.12. Psychoeducation for Families and Patients
4. Future Directions
4.1. Phase I: Identification
4.2. Phase II: Collaboration
4.3. Phase III: Planned Improvements
5. Methods
Screening and Selection of Evidence of Women-Specific Care Needs in Schizophrenia
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Seeman, M.V.; Cohen, R. A service for women with schizophrenia. Psychiatr. Serv. 1998, 49, 674–677. [Google Scholar] [CrossRef] [PubMed]
- Owen, M.J.; O'Donovan, M.C. Schizophrenia and the neurodevelopmental continuum: Evidence from genomics. World Psychiatry 2017, 16, 227–235. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Suvisaari, J.M.; Taxell-Lassas, V.; Pankakoski, M.; Haukka, J.K.; Lönnqvist, J.K.; Häkkinen, L.T. Obstetric complications as risk factors for schizophrenia spectrum psychoses in offspring of mothers with psychotic disorder. Schizophr. Bull. 2013, 39, 1056–1066. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pence, A.Y.; Pries, L.K.; Ferrara, M.; Rutten, B.P.F.; van Os, J.; Guloksuz, S. Gender differences in the association between environment and psychosis. Schizophr. Res. 2022, 243, 120–137. [Google Scholar] [CrossRef] [PubMed]
- Brzezinski-Sinai, N.A.; Brzezinski, A. Schizophrenia and Sex Hormones: What Is the Link? Front. Psychiatry 2020, 11, 693. [Google Scholar] [CrossRef]
- Abel, K.M.; Drake, R.; Goldstein, J.M. Sex differences in schizophrenia. Int. Rev. Psychiatry 2010, 22, 417–428. [Google Scholar] [CrossRef]
- Posada Correa, A.M.; Andrade Carrillo, R.A.; Suarez Vega, D.C.; Gómez Cano, S.; Agudelo Arango, L.G.; Tabares Builes, L.F.; Agudelo García, Á.M.; Uribe Villa, E.; Aguirre-Acevedo, D.C.; López-Jaramillo, C. Sexual and Reproductive Health in Patients with Schizophrenia and Bipolar Disorder. Rev. Colomb. Psiquiatr. 2020, 49, 15–22. [Google Scholar] [CrossRef]
- Thomas, N.; Gurvich, C.; Hudaib, A.R.; Gavrilidis, E.; de Castella, R.A.; Thomas, E.H.; Kulkarni, J. Serum estradiol as a blood-based biomarker predicting hormonal treatment outcomes in women with schizophrenia. Psychoneuroendocrinology 2021, 126, 105165. [Google Scholar] [CrossRef] [PubMed]
- Heitz, U.; Studerus, E.; Menghini-Müller, S.; Papmeyer, M.; Egloff, L.; Ittig, S.; Navarra, A.; Andreou, C.; Riecher-Rössler, A. Gender differences in first self-perceived signs and symptoms in patients with an at-risk mental state and first-episode psychosis. Early Interv. Psychiatry 2019, 13, 582–588. [Google Scholar] [CrossRef]
- Spitz, A.; Studerus, E.; Koranyi, S.; Rapp, C.; Ramyead, A.; Ittig, S.; Heitz, U.; Uttinger, M.; Riecher-Rössler, A. Correlations between self-rating and observer-rating of psychopathology in at-risk mental state and first-episode psychosis patients: Influence of disease stage and gender. Early Interv. Psychiatry 2017, 11, 461–470. [Google Scholar] [CrossRef] [Green Version]
- Riecher-Rössler, A.; Butler, S.; Kulkarni, J. Sex and gender differences in schizophrenic psychoses-a critical review. Arch. Women’s Ment. Health 2018, 21, 627–648. [Google Scholar] [CrossRef] [PubMed]
- González-Rodríguez, A.; Seeman, M.V.; Díaz-Pons, A.; Ayesa-Arriola, R.; Natividad, M.; Calvo, E.; Monreal, J.A. Do sex/gender and menopause influence the psychopathology and comorbidity observed in delusional disorders? J. Clin. Med. 2022, 11, 4550. [Google Scholar] [CrossRef] [PubMed]
- Li, R.; Ma, X.; Wang, G.; Yang, J.; Wang, C. Why sex differences in schizophrenia? J. Transl. Neurosci. 2016, 1, 37–42. [Google Scholar]
- Seeman, M.V. Sex differences in schizophrenia relevant to clinical care. Expert. Rev. Neurother. 2021, 21, 443–453. [Google Scholar] [CrossRef] [PubMed]
- Seeman, M.V.; González-Rodríguez, A. Stratification by sex and hormone level when contrasting men and women in schizophrenia trials will improve personalized treatment. J. Pers. Med. 2021, 11, 929. [Google Scholar] [CrossRef]
- Mazza, M.; Caroppo, E.; De Berardis, D.; Marano, G.; Avallone, C.; Kotzalidis, G.D.; Janiri, D.; Moccia, L.; Simonetti, A.; Conte, E.; et al. Psychosis in women: Time for personalized treatment. J. Pers. Med. 2021, 11, 1279. [Google Scholar] [CrossRef] [PubMed]
- Turrone, P.; Seeman, M.V.; Silvestri, S. Estrogen receptor activation and tardive dyskinesia. Can. J. Psychiatry 2000, 45, 288–290. [Google Scholar] [CrossRef] [Green Version]
- Álvarez, A.; Guàrdia, A.; González-Rodríguez, A.; Betriu, M.; Palao, D.; Monreal, J.A.; Soria, V.; Labad, J. A systematic review and meta-analysis of suicidality in psychotic disorders: Stratified analyses by psychotic subtypes, clinical setting and geographical region. Neurosci. Biobehav. Rev. 2022, 143, 104964. [Google Scholar] [CrossRef]
- Seeman, M.V. Suicide among women with schizophrenia spectrum disorders. J. Psychiatr. Pract. 2009, 15, 235–242. [Google Scholar] [CrossRef]
- Sommer, I.E.; Brand, B.A.; Gangadin, S.; Tanskanen, A.; Tiihonen, J.; Taipale, H. Women with schizophrenia-spectrum disorders after menopause: A vulnerable group for relapse. Schizophr. Bull. 2022, 49, 136–143. [Google Scholar] [CrossRef]
- Goldstein, J.M.; Cohen, L.S.; Horton, N.J.; Lee, H.; Andersen, S.; Tohen, M.; Crawford, A.; Tollefson, G. Sex differences in clinical response to olanzapine compared with haloperidol. Psychiatry Res. 2002, 110, 27–37. [Google Scholar] [CrossRef]
- Kulkarni, J. Estrogen—A key neurosteroid in the understanding and treatment of mental illness in women. Psychiatry Res. 2022, 319, 114991. [Google Scholar] [CrossRef] [PubMed]
- Paderina, D.Z.; Boiko, A.S.; Pozhidaev, I.V.; Mednova, I.A.; Goncharova, A.A.; Bocharova, A.V.; Fedorenko, O.Y.; Kornetova, E.G.; Semke, A.V.; Bokhan, N.A.; et al. The gender-specific association of drd2 polymorphism with metabolic syndrome in patients with schizophrenia. Genes 2022, 13, 1312. [Google Scholar] [CrossRef]
- Pu, C.; Huang, B.; Zhou, T.; Cheng, Z.; Wang, Y.; Shi, C.; Yu, X. Gender differences in the first-year antipsychotic treatment for Chinese first-episode schizophrenia. Neuropsychiatr. Dis. Treat. 2020, 16, 3145–3152. [Google Scholar] [CrossRef] [PubMed]
- Liang, Q.; Wang, D.; Zhou, H.; Chen, D.; Xiu, M.; Cui, L.; Zhang, X. Tardive dyskinesia in Chinese patients with schizophrenia: Prevalence, clinical correlates and relationship with cognitive impairment. J. Psychiatr. Res. 2022, 151, 181–187. [Google Scholar] [CrossRef] [PubMed]
- González-Rodríguez, A.; Catalán, R.; Penadés, R.; Ruiz Cortés, V.; Torra, M.; Seeman, M.V.; Bernardo, M. Antipsychotic response worsens with postmenopausal duration in women with schizophrenia. J. Clin. Psychopharmacol. 2016, 36, 580–587. [Google Scholar] [CrossRef]
- Brzezinski, A.; Brzezinski-Sinai, N.A.; Seeman, M.V. Treating schizophrenia during menopause. Menopause 2017, 24, 582–588. [Google Scholar] [CrossRef]
- Kulkarni, J.; Fitzgerald, P.; Seeman, M.V. Clinical needs of women with schizophrenia. In Pharmacological and Psychosocial Treatments in Schizophrenia, 3rd ed.; Castle, D.J., Copolov, D.L., Wykes, T., Mueser, K.T., Eds.; Informa Healthcare, Ltd.: London, UK, 2012; pp. 183–201. [Google Scholar]
- González-Rodríguez, A.; Seeman, M.V.; Álvarez, A.; Guàrdia, A.; Sanz, N.; Fucho, G.F.; Palao, D.J.; Labad, J. Care for women with delusional disorder: Towards a specialized approach. Women 2021, 1, 46–59. [Google Scholar] [CrossRef]
- Bergemann, N.; Parzer, P.; Runnebaum, B.; Resch, F.; Mundt, C. Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia. Psychol. Med. 2007, 37, 1427–1436. [Google Scholar] [CrossRef]
- Reilly, T.J.; Sagnay de la Bastida, V.C.; Joyce, D.W.; Cullen, A.E.; McGuire, P. Exacerbation of psychosis during the perimenstrual phase of the menstrual cycle: Systematic review and meta-analysis. Schizophr. Bull. 2020, 46, 78–90. [Google Scholar] [CrossRef]
- Kiliçaslan, E.E.; Erol, A.; Zengin, B.; Çetinay Aydin, P.; Mete, L. Association between age at onset of schizophrenia and age at menarche. Noro. Psikiyatr. Ars. 2014, 51, 211–215. [Google Scholar] [CrossRef]
- Riecher-Rössler, A.; Häfner, H.; Stumbaum, M.; Schmidt, R. Do estrogens have an antipsychotic action? Fortschr. Neurol. Psychiatr. 1994, 62, 22–28. [Google Scholar] [CrossRef]
- Zerihun, T.; Sorsdahl, K.; Hanlon, C. Family planning for women with severe mental illness in rural Ethiopia: A qualitative study. Reprod. Health 2021, 18, 191. [Google Scholar] [CrossRef]
- Taylor, C.; Stewart, R.; Gibson, R.; Pasupathy, D.; Shetty, H.; Howard, L. Birth without intervention in women with severe mental illness: Cohort study. Br. J. Psych. Open 2022, 8, e50. [Google Scholar] [CrossRef]
- Chang, S.; Jeyagurunathan, A.; Lau, J.H.; Shafie, S.; Samari, E.; Cetty, L.; Mok, Y.M.; Verma, S.; Subramaniam, M. Problematic drug use among outpatients with schizophrenia and related psychoses. Front. Psychiatry 2021, 12, 762988. [Google Scholar] [CrossRef]
- Kouidrat, Y.; Amad, A.; Lalau, J.D.; Loas, G. Eating disorders in schizophrenia: Implications for research and management. Schizophr. Res. Treatment 2014, 2014, 791573. [Google Scholar] [CrossRef] [Green Version]
- Thara, R.; Kamath, S. Women and schizophrenia. Indian J. Psychiatry 2015, 57 (Suppl. 2), S246–S251. [Google Scholar] [CrossRef]
- Zhang, X.; Dupre, M.E.; Qiu, L.; Zhou, W.; Zhao, Y.; Gu, D. Age and sex differences in the association between access to medical care and health outcomes among older Chinese. BMC Health Serv. Res. 2018, 18, 1004. [Google Scholar] [CrossRef]
- Seeman, M.V. Psychosis and Physical Comorbidity. In Mental Health and Illness of Women. Mental Health and Illness Worldwide; Chandra, P., Herrman, H., Fisher, J., Riecher-Rössler, A., Eds.; Springer: Singapore, 2019; pp. 1–28. [Google Scholar] [CrossRef]
- Lindamer, L.A.; Buse, D.C.; Auslander, L.; Unützer, J.; Bartels, S.J.; Jeste, D.V. A comparison of gynecological variables and service use among older women with and without schizophrenia. Psychiatr. Serv. 2003, 54, 902–904. [Google Scholar] [CrossRef]
- Irwin, K.E.; Callaway, C.A.; Corveleyn, A.E.; Pappano, C.R.; Barry, M.J.; Tiersma, K.M.; Nelson, Z.E.; Fields, L.E.; Pirl, W.F.; Greer, J.A.; et al. Study protocol for a randomized trial of bridge: Person-centered collaborative care for serious mental illness and cancer. Contemp. Clin. Trials 2022, 123, 106975. [Google Scholar] [CrossRef]
- Seeman, M.V. Preventing breast cancer in women with schizophrenia. Acta Psychiatr. Scand. 2011, 123, 107–117. [Google Scholar] [CrossRef]
- Wootten, J.C.; Wiener, J.C.; Blanchette, P.S.; Anderson, K.K. Cancer incidence and stage at diagnosis among people with psychotic disorders: Systematic review and meta-analysis. Cancer Epidemiol. 2022, 80, 102233. [Google Scholar] [CrossRef]
- Kalucy, M.J.; Grunstein, R.; Lambert, T.; Glozier, N. Obstructive sleep apnoea and schizophrenia--a research agenda. Sleep Med. Rev. 2013, 17, 357–365. [Google Scholar] [CrossRef]
- Seeman, M.V. Diagnosis and treatment of sleep apnoea in women with schizophrenia. J. Ment. Health 2014, 23, 191–196. [Google Scholar] [CrossRef]
- Szaulińska, K.; Wichniak, A. BMI-NECK: A simple assessment of risk of obstructive sleep apnea in schizophrenia. J. Psychiatr. Res. 2020, 125, 33–37. [Google Scholar] [CrossRef]
- Seeman, M.V. The role of mental health services in addressing HIV infection among women with serious mental illness. Psychiatr. Serv. 2015, 66, 966–974. [Google Scholar] [CrossRef]
- Velligan, D.I.; Weiden, P.J.; Sajatovic, M.; Scott, J.; Carpenter, D.; Ross, R.; Docherty, J.P. Strategies for addressing adherence problems in patients with serious and persistent mental illness: Recommendations from the expert consensus guidelines. J. Psychiatr. Pract. 2010, 16, 306–324. [Google Scholar] [CrossRef]
- Druschky, K.; Bleich, S.; Grohmann, R.; Burda, K.; Frieling, H.; Hillemacher, T.; Neyazi, A.; Stübner, S.; Toto, S. Severe hair loss associated with psychotropic drugs in psychiatric inpatients-Data from an observational pharmacovigilance program in German-speaking countries. Eur. Psychiatry 2018, 54, 117–123. [Google Scholar] [CrossRef]
- Edinoff, A.N.; Silverblatt, N.S.; Vervaeke, H.E.; Horton, C.C.; Girma, E.; Kaye, A.D.; Kaye, A.; Kaye, J.S.; Garcia, A.J.; Neuchat, E.E.; et al. Hyperprolactinemia, clinical considerations, and infertility in women on antipsychotic medications. Psychopharmacol. Bull. 2021, 51, 131–148. [Google Scholar]
- Crews, M.P.; Howes, O.D. Is antipsychotic treatment linked to low bone mineral density and osteoporosis? A review of the evidence and the clinical implications. Hum. Psychopharmacol. 2012, 27, 15–23. [Google Scholar] [CrossRef] [Green Version]
- Rodolico, A.; Siafis, S.; Bighelli, I.; Samara, M.T.; Hansen, W.P.; Salomone, S.; Aguglia, E.; Cutrufelli, P.; Bauer, I.; Baeckers, L.; et al. Antipsychotic dose reduction compared to dose continuation for people with schizophrenia. Cochrane Database Syst. Rev. 2022, 11, CD014384. [Google Scholar]
- Chen, C.Y.; Lane, H.Y.; Lin, C.H. Effects of antipsychotics on bone mineral density in patients with schizophrenia: Gender differences. Clin. Psychopharmacol. Neurosci. 2016, 14, 238–249. [Google Scholar] [CrossRef] [Green Version]
- Teodorescu, A.; Ifteni, P.; Moga, M.A.; Burtea, V.; Bigiu, N. Dilemma of treating schizophrenia during pregnancy: A case series and a review of literature. BMC Psychiatry 2017, 17, 311. [Google Scholar] [CrossRef] [Green Version]
- Gentile, S.; Fusco, M.L. Schizophrenia and motherhood. Psychiatry Clin. Neurosci. 2019, 73, 376–385. [Google Scholar] [CrossRef] [PubMed]
- Dazzan, P. Schizophrenia during pregnancy. Curr. Opin. Psychiatry 2021, 34, 238–244. [Google Scholar] [CrossRef]
- Lin, H.C.; Chen, I.J.; Chen, Y.H.; Lee, H.C.; Wu, F.J. Maternal schizophrenia and pregnancy outcome: Does the use of antipsychotics make a difference? Schizophr. Res. 2010, 116, 55–60. [Google Scholar] [CrossRef] [PubMed]
- Patrick, P.M.; Reupert, A.E.; McLean, L.A. Relational trajectories in families with parental mental illness: A grounded theory approach. BMC Psychol. 2020, 8, 68. [Google Scholar] [CrossRef]
- Vigod, S.N.; Kurdyak, P.A.; Dennis, C.L.; Gruneir, A.; Newman, A.; Seeman, M.V.; Rochon, P.A.; Anderson, G.M.; Grigoriadis, S.; Ray, J.G. Maternal and newborn outcomes among women with schizophrenia: A retrospective population-based cohort study. BJOG 2014, 121, 566–574. [Google Scholar] [CrossRef]
- Heinonen, E.; Forsberg, L.; Nörby, U.; Wide, K.; Källén, K. Neonatal morbidity after fetal exposure to antipsychotics: A national register-based study. BMJ Open. 2022, 12, e061328. [Google Scholar] [CrossRef] [PubMed]
- Seeman, M.V. Antipsychotic-induced somnolence in mothers with schizophrenia. Psychiatr. Q. 2012, 83, 83–89. [Google Scholar] [CrossRef]
- Thara, R.; Kamath, S.; Kumar, S. Women with schizophrenia and broken marriages—doubly disadvantaged? Part I: Patient perspective. Int. J. Soc. Psychiatry 2003, 49, 225–232. [Google Scholar] [CrossRef] [PubMed]
- Thara, R.; Kamath, S.; Kumar, S. Women with schizophrenia and broken marriages—doubly disadvantaged? Part II: Family perspective. Int. J. Soc. Psychiatry 2003, 49, 233–240. [Google Scholar] [CrossRef]
- Seeman, M.V. Intervention to prevent child custody loss in mothers with schizophrenia. Schizophr. Res. Treatment 2012, 2012, 796763. [Google Scholar] [CrossRef] [Green Version]
- Mercolini, L. Editorial: Advances in therapeutic drug monitoring of psychiatric subjects: Analytical strategies and clinical approaches. Front. Psychiatry 2022, 13, 1056380. [Google Scholar] [CrossRef]
- Cahaya, N.; Kristina, S.A.; Widayanti, A.W.; Green, J. Interventions to improve medication adherence in people with schizophrenia: A systematic review. Patient Prefer. Adherence 2022, 16, 2431–2449. [Google Scholar] [CrossRef]
- Pennazio, F.; Brasso, C.; Villari, V.; Rocca, P. Current status of therapeutic drug monitoring in mental health treatment: A review. Pharmaceutics 2022, 14, 2674. [Google Scholar] [CrossRef] [PubMed]
- Brand, B.A.; Haveman, Y.R.A.; de Beer, F.; de Boer, J.N.; Dazzan, P.; Sommer, I.E.C. Antipsychotic medication for women with schizophrenia spectrum disorders. Psychol. Med. 2021, 52, 1–15. [Google Scholar] [CrossRef]
- González-Rodríguez, A.; Seeman, M.V. Addressing delusions in women and men with delusional disorder: Key points for clinical management. Int. J. Environ. Res. Public. Health 2020, 17, 4583. [Google Scholar] [CrossRef] [PubMed]
- Aragonès, E.; López-Cortacans, G.; Cardoner, N.; Tomé-Pires, C.; Porta-Casteràs, D.; Palao, D.; INDIIResearch Team. Barriers, facilitators, and proposals for improvement in the implementation of a collaborative care program for depression: A qualitative study of primary care physicians and nurses. BMC Health Serv. Res. 2022, 22, 446. [Google Scholar] [CrossRef]
- Andreu, M.; Alcaraz, N.; Gual, A.; Segura, L.; Barrio, P. Primary care provider expectations of addiction services and patients in Spain. Fam. Pract. 2022, 39, 269–274. [Google Scholar] [CrossRef]
- Hwong, A.; Wang, K.; Bent, S.; Mangurian, C. Breast cancer screening in women with schizophrenia: A systematic review and meta-analysis. Psychiatr. Serv. 2020, 71, 263–268. [Google Scholar] [CrossRef] [PubMed]
- Cather, C.; Pachas, G.N.; Cieslak, K.M.; Evins, A.E. Achieving smoking cessation in individuals with schizophrenia: Special considerations. C.N.S. Drugs. 2017, 31, 471–481. [Google Scholar] [CrossRef]
- Kamitaki, N.; Sekar, A.; Handsaker, R.E.; de Rivera, H.; Tooley, K.; Morris, D.L.; Taylor, K.E.; Whelan, C.W.; Tombleson, P.; Loohuis, L.M.O.; et al. Complement genes contribute sex-biased vulnerability in diverse disorders. Nature 2020, 582, 577–581. [Google Scholar] [CrossRef]
- Björlin Avdic, H.; Butwicka, A.; Nordenström, A.; Almqvist, C.; Nordenskjöld, A.; Engberg, H.; Frisén, L. Neurodevelopmental and psychiatric disorders in females with Turner syndrome: A population-based study. J. Neurodev. Disord. 2021, 13, 51. [Google Scholar] [CrossRef] [PubMed]
- Gui, Y.; Bai, W.; Xu, J.; Duan, X.; Zhan, F.; Zhao, C.; Jiang, Z.; Li, Z.; Wu, L.; Liu, S.; et al. Sex differences in systemic lupus erythematosus (SLE): An inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII. Chin. Med. J. 2022, 135, 2191–2199. [Google Scholar] [CrossRef] [PubMed]
- Ngo, S.T.; Steyn, F.J.; McCombe, P.A. Gender differences in autoimmune disease. Front. Neuroendocrinol. 2014, 35, 347–369. [Google Scholar] [CrossRef] [Green Version]
- Sporinova, B.; Manns, B.; Tonelli, M.; Hemmelgarn, B.; MacMaster, F.; Mitchell, N.; Au, F.; Ma, Z.; Weaver, R.; Quinn, A. Association of mental health disorders with health care utilization and costs among adults with chronic disease. JAMA Netw. Open 2019, 2, e199910. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lawrence, W.R.; Kuliszewski, M.G.; Hosler, A.S.; Leinung, M.C.; Zhang, X.; Zhang, W.; Du, Z.; Schymura, M.J.; Boscoe, F.P. Association between preexisting mental illnesses and mortality among medicaid-insured women diagnosed with breast cancer. Soc. Sci. Med. 2021, 270, 113643. [Google Scholar] [CrossRef]
- Nemani, K.L.; Greene, M.C.; Ulloa, M.; Vincenzi, B.; Copeland, P.M.; Al-Khadari, S.; Henderson, D.C. Clozapine, diabetes mellitus, cardiovascular risk and mortality: Results of a 21-year naturalistic study in patients with schizophrenia and schizoaffective disorder. Clin. Schizophr. Relat. Psychoses. 2019, 12, 168–176. [Google Scholar] [CrossRef]
- Westman, J.; Eberhard, J.; Gaughran, F.P.; Lundin, L.; Stenmark, R.; Edman, G.; Eriksson, S.V.; Jedenius, E.; Rydell, P.; Overgaard, K.; et al. Outcome of a psychosocial health promotion intervention aimed at improving physical health and reducing alcohol use in patients with schizophrenia and psychotic disorders (MINT). Schizophr. Res. 2019, 208, 138–144. [Google Scholar] [CrossRef] [PubMed]
- Mortier, P.; Vilagut, G.; Puértolas Gracia, B.; De Inés Trujillo, A.; Alayo Bueno, I.; Ballester Coma, L.; Blasco Cubedo, M.J.; Cardoner, N.; Colls, C.; Elices, M.; et al. Catalonia Suicide Risk Code Epidemiology (CSRC-Epi) study: Protocol for a population-representative nested case-control study of suicide attempts in Catalonia, Spain. BMJ Open 2020, 10, e037365. [Google Scholar] [CrossRef] [PubMed]
- Pérez, V.; Elices, M.; Prat, B.; Vieta, E.; Blanch, J.; Alonso, J.; Pifarré, J.; Mortier, P.; Cebrià, A.I.; Campillo, M.T.; et al. The Catalonia Suicide Risk Code: A secondary prevention program for individuals at risk of suicide. J. Affect. Disord. 2020, 268, 201–205. [Google Scholar] [CrossRef] [PubMed]
- González-Rodríguez, A.; Guàrdia, A.; Álvarez-Pedrero, A.; Betriu, M.; Cobo, J.; Acebillo, S.; Monreal, J.A.; Seeman, M.V.; Palao, D.; Labad, J. Women with schizophrenia over the life span: Health promotion, treatment and outcomes. Int. J. Environ. Res. Public. Health 2020, 17, 5594. [Google Scholar] [CrossRef] [PubMed]
- Alves, S.P.; Costa, T.; Ribeiro, I.; Néné, M.; Sequeira, C. Perinatal mental health counselling programme: A scoping review. Patient. Educ. Couns. 2023, 106, 170–179. [Google Scholar] [CrossRef] [PubMed]
- Healy, S.J.; Lewin, J.; Butler, S.; Vaillancourt, K.; Seth-Smith, F. Affect recognition and the quality of mother-infant interaction: Understanding parenting difficulties in mothers with schizophrenia. Arch. Womens Ment. Health 2016, 19, 113–124. [Google Scholar] [CrossRef]
- Layton, H.; Owais, S.; Savoy, C.D.; Van Lieshout, R.J. Depression, Anxiety, and mother-infant bonding in women seeking treatment for postpartum depression before and during the Covid-19 pandemic. J. Clin. Psychiatry 2021, 82, 21m13874. [Google Scholar] [CrossRef]
- Cesar, P.; King, R. Social workers' beliefs about the interventions for schizophrenia and depression: A comparison with the public and other health professionals—An Australian analysis. Br. J. Soc. Work. 2015, 45, 1750–1770. [Google Scholar] [CrossRef] [Green Version]
- Caton, C.L.; Shrout, P.E.; Dominguez, B.; Eagle, P.F.; Opler, L.A.; Cournos, F. Risk factors for homelessness among women with schizophrenia. Am. J. Public Health 1995, 85 Pt 1, 1153–1156. [Google Scholar] [CrossRef] [Green Version]
- Li, K.Y.; Wu, Y.H.; Chen, H.Y. Predictors of personal recovery for individuals with schizophrenia spectrum disorders living in the community. Clin. Psychol. Psychother. 2022, 30, 179–187. [Google Scholar] [CrossRef]
- Nilsson, S.F.; Nordentoft, M.; Hjorthøj, C. Individual-level predictors for becoming homeless and exiting homelessness: A systematic review and meta-analysis. J. Urban Health 2019, 96, 741–750. [Google Scholar] [CrossRef]
- Stergiopoulos, V.; Mejia-Lancheros, C.; Nisenbaum, R.; Wang, R.; Lachaud, J.; O'Campo, P.; Hwang, S.W. Long-term effects of rent supplements and mental health support services on housing and health outcomes of homeless adults with mental illness: Extension study of the At Home/Chez Soi randomised controlled trial. Lancet Psychiatry 2019, 6, 915–925. [Google Scholar] [CrossRef] [PubMed]
- O'Campo, P.; Stergiopoulos, V.; Nir, P.; Levy, M.; Misir, V.; Chum, A.; Arbach, B.; Nisenbaum, R.; To, M.J.; Hwang, S.W. How did a Housing First intervention improve health and social outcomes among homeless adults with mental illness in Toronto? Two-year outcomes from a randomised trial. BMJ Open 2016, 6, 010581. [Google Scholar] [CrossRef]
- Lanham, J.S.; White, P.; Gaffney, B. Care of people experiencing homelessness. Am. Fam. Physician 2022, 106, 684–693. [Google Scholar] [PubMed]
- Reifler, B.V.; Bruce, M.L. Home-based mental health services for older adults: A review of ten model programs. Am. J. Geriatr. Psychiatry 2014, 22, 241–247. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sharifi, V.; Tehranidoost, M.; Yunesian, M.; Amini, H.; Mohammadi, M.; Jalali Roudsari, M. Effectiveness of a low-intensity home-based aftercare for patients with severe mental disorders: A 12-month randomized controlled study. Community Ment. Health J. 2012, 48, 766–770. [Google Scholar] [CrossRef]
- Shalaby, R.A.H.; Agyapong, V.I.O. Peer support in mental health: Literature review. JMIR Ment. Health 2020, 7, e15572. [Google Scholar] [CrossRef]
- Rice, C.; Ingram, E.; O'Mahen, H. A qualitative study of the impact of peer support on women’s mental health treatment experiences during the perinatal period. BMC Pregnancy Childbirth. 2022, 22, 689. [Google Scholar] [CrossRef]
- Taylor, B.L.; Billings, J.; Morant, N.; Bick, D.; Johnson, S. Experiences of how services supporting women with perinatal mental health difficulties work with their families: A qualitative study in England. BMJ Open 2019, 9, e030208. [Google Scholar] [CrossRef]
- Ochoa, S.; Usall, J.; Cobo, J.; Labad, X.; Kulkarni, J. Gender differences in schizophrenia and first-episode psychosis: A comprehensive literature review. Schizophr. Res. Treatment. 2012, 2012, 916198. [Google Scholar] [CrossRef] [Green Version]
- Prat, G.; Escandell, M.J.; Garcia-Franco, M.; Martín-Martínez, J.R.; Tortades, I.; Vilamala, S.; Calderón, M.; Torras, R.; Ochoa, S.; Casas-Anguera, E. Gender differences in social functioning in people with schizophrenia in psychosocial rehabilitation services using one-dimensional and multidimensional instruments. Compr. Psychiatry 2018, 87, 120–122. [Google Scholar] [CrossRef]
- Ercan Doğu, S.; Örsel, S. The relationship between psychopathology, occupational balance, and quality of life among people with schizophrenia. Aust. Occup. Ther. J. 2022; in press. [Google Scholar]
- Foruzandeh, N.; Parvin, N. Occupational therapy for inpatients with chronic schizophrenia: A pilot randomized controlled trial. Jpn. J. Nurs. Sci. 2013, 10, 136–141. [Google Scholar] [CrossRef] [PubMed]
- Froehlich, J.; Donovan, A.; Ravlin, E.; Fortier, A.; North, J.; Bloch, M.K. Daily routines of breastfeeding mothers. Work 2015, 50, 433–442. [Google Scholar] [CrossRef]
- Curcic, D.; Stojmenovic, T.; Djukic-Dejanovic, S.; Dikic, N.; Vesic-Vukasinovic, M.; Radivojevic, N.; Andjelkovic, M.; Borovcanin, M.; Djokic, G. Positive impact of prescribed physical activity on symptoms of schizophrenia: Randomized clinical trial. Psychiatr. Danub. 2017, 29, 459–465. [Google Scholar] [CrossRef] [Green Version]
- Lee, S.H.; Kim, G.; Kim, C.E.; Ryu, S. Physical activity of patients with chronic schizophrenia and related clinical factors. Psychiatry Investig. 2018, 15, 811–817. [Google Scholar] [CrossRef] [Green Version]
- Sevillano-Jiménez, A.; Romero-Saldaña, M.; García-Rodríguez, M.; Molina-Luque, R.; Molina-Recio, G. Nutritional impact and eating pattern changes in schizophrenic spectrum disorders after health education program on symbiotic dietary modulation offered by specialised psychiatric nursing-two-arm randomised clinical trial. Nutrients 2022, 14, 5388. [Google Scholar] [CrossRef] [PubMed]
- Girdler, S.J.; Confino, J.E.; Woesner, M.E. Exercise as a treatment for schizophrenia: A review. Psychopharmacol. Bull. 2019, 49, 56–69. [Google Scholar]
- Arnautovska, U.; Kesby, J.P.; Korman, N.; Rebar, A.L.; Chapman, J.; Warren, N.; Rossell, S.L.; Dark, F.L.; Siskind, D. Biopsychology of physical activity in people with schizophrenia: An integrative perspective on barriers and intervention strategies. Neuropsychiatr. Dis. Treat. 2022, 18, 2917–2926. [Google Scholar] [CrossRef] [PubMed]
- Sari, A.; Duman, Z.Ç. Effects of the family support and psychoeducation program based on the Calgary Family Intervention Model on the coping, psychological distress and psychological resilience levels of the family caregivers of chronic psychiatric patients. Arch. Psychiatr. Nurs. 2022, 41, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Lippi, G. Schizophrenia in a member of the family: Burden, expressed emotion and addressing the needs of the whole family. S. Afr. J. Psychiatr. 2016, 22, 922. [Google Scholar] [CrossRef] [Green Version]
- Bora, S.T.; Buldukoğlu, K.; Bailey, D.E., Jr. Effectiveness of an uncertainty management psychoeducation program for schizophrenia caregivers: A randomized controlled trial. J. Am. Psychiatr. Nurses. Assoc. 2022; in press. [Google Scholar]
- Amsalem, D.; Jankowski, S.E.; Pagdon, S.; Valeri, L.; Smith, S.; Yang, L.H.; Markowitz, J.C.; Lewis-Fernández, R.; Dixon, L.B. “It is hard to be a woman with schizophrenia”: Randomized controlled trial of a brief video intervention to reduce public stigma in young adults. J. Clin. Psychiatry 2022, 84, 22m14534. [Google Scholar] [CrossRef]
- Kay, S.R.; Fiszbein, A.; Opler, L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13, 261–276. [Google Scholar] [CrossRef]
- Peralta, V.; Cuesta, M.J. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res. 1994, 53, 31–40. [Google Scholar] [CrossRef]
- Apiquian, R.; Elena Ulloa, R.; Herrera-Estrella, M.; Moreno-Gómez, A.; Erosa, S.; Contreras, V.; Nicolini, H. Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia. Schizophr. Res. 2009, 112, 181–186. [Google Scholar] [CrossRef]
- Garcia-Portilla, M.P.; Saiz, P.A.; Bousoño, M.; Bascaran, M.T.; Guzmán-Quilo, C.; Bobes, J.; en nombre del grupo de validación de la versión española de la escala de Funcionamiento Personal y Social (PSP). Validation of the Spanish Personal and Social Performance scale (PSP) in outpatients with stable and unstable schizophrenia. Rev. Psiquiatr. Salud Ment. 2011, 4, 9–18. [Google Scholar] [CrossRef] [PubMed]
- Endicott, J.; Spitzer, R.L.; Fleiss, J.L.; Cohen, J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry 1976, 33, 766–771. [Google Scholar] [CrossRef]
- Haro, J.M.; Kamath, S.A.; Ochoa, S.; Novick, D.; Rele, K.; Fargas, A.; Rodríguez, M.J.; Rele, R.; Orta, J.; Kharbeng, A.; et al. The Clinical Global Impression—Schizophrenia scale: A simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr. Scand. Suppl. 2003, 416, 16–23. [Google Scholar] [CrossRef] [PubMed]
- Speak, B.L.; Hay, P.; Muncer, S.J. HoNOS—Their utility for payment by results in mental Health. Int. J. Health Care Qual. Assur. 2015, 28, 115–128. [Google Scholar] [CrossRef] [PubMed]
- Orrell, M.; Yard, P.; Handysides, J.; Schapira, R. Validity and reliability of the Health of the Nation Outcome Scales in psychiatric patients in the community. Br. J. Psychiatry 1999, 174, 409–412. [Google Scholar] [CrossRef]
- Vázquez, F.L.; Torres, A.; Otero, P.; Blanco, V.; Attkisson, C.C. Psychometric properties of the Castilian Spanish Version of the Client Satisfaction Questionnaire (CSQ-8). Curr. Psychol. 2019, 38, 829–835. [Google Scholar] [CrossRef]
- Pedersen, H.; Havnen, A.; Brattmyr, M.; Attkisson, C.C.; Lara-Cabrera, M.L. A digital Norwegian version of the client satisfaction questionnaire. 8: Factor validity and internal reliability in outpatient mental health care. BMC Psychiatry 2022, 22, 671. [Google Scholar] [CrossRef]
Program | Specifics | Status |
---|---|---|
Therapeutic drug monitoring (TDM)/adherence program | Clinical monitoring of symptoms, safety, and tolerability of psychotropic meds Lab monitoring measuring plasma drug concentrations Evaluation of risk/benefit | Offered currently |
Individual/group patient and family sessions | Diagnostic assessment Symptom management Individual and family interventions | Offered currently |
Collaborative programs (primary care) | Close collaboration to ensure timely referrals | Offered currently |
Collaborative programs with other medical specialties | Ensuring effective referrals Special attention to particular health needs (gynecology, oncology, cardiology, endocrinology) | In planning phase |
Prevention and intervention of suicide risk | Early identification of suicide risk Effective interventions | Offered currently |
Perinatal mental health | Preconception counseling, promotion of mental health and treatment during the 1st, 2nd, 3rd trimester, postpartum and lactation periods | Offered currently |
Social services | Special care for single mothers, family issues, trauma, domestic abuse, sexual exploitation | Offered currently |
Home-based services | Home visits and short-term intensive community support | Offered currently |
Peer support | Peer counseling and support | Offered currently |
Occupational therapies | Activity planning to improve function and help recovery | In planning phase |
Physical activity and leisure programs | Engagement in physical activity programs for health and leisure | In planning phase |
Psychoeducation for families and patients | Exchange of knowledge Reciprocal understanding | In planning phase |
Objectives | Outcomes | |
---|---|---|
Phase I: Identification of eligible women | To identify all women with schizophrenia spectrum disorders | Baseline documentation on health indices in our clientele |
Phase II: Collaboration with other medical specialties | To make & receive appropriate referrals | Improved screening, prevention, and early intervention of disease |
Phase III: Implementation of other projected programs | To implement new planned programs as part of comprehensive care | Improved medical, occupational, social, and mental health and quality of life |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
González-Rodríguez, A.; Seeman, M.V.; Natividad, M.; Barrio, P.; Román, E.; Balagué, A.; Paolini, J.P.; Monreal, J.A. Review of Male and Female Care Needs in Schizophrenia: A New Specialized Clinical Unit for Women. Women 2023, 3, 107-120. https://doi.org/10.3390/women3010009
González-Rodríguez A, Seeman MV, Natividad M, Barrio P, Román E, Balagué A, Paolini JP, Monreal JA. Review of Male and Female Care Needs in Schizophrenia: A New Specialized Clinical Unit for Women. Women. 2023; 3(1):107-120. https://doi.org/10.3390/women3010009
Chicago/Turabian StyleGonzález-Rodríguez, Alexandre, Mary V. Seeman, Mentxu Natividad, Pablo Barrio, Eloïsa Román, Ariadna Balagué, Jennipher Paola Paolini, and José Antonio Monreal. 2023. "Review of Male and Female Care Needs in Schizophrenia: A New Specialized Clinical Unit for Women" Women 3, no. 1: 107-120. https://doi.org/10.3390/women3010009